Cartesian Therapeutics, Inc. · NASDAQ:RNAC
FMR LLC reported a 8.30% stake in Cartesian Therapeutics, Inc. (Schedule 13G/A)
Event Sep 30, 2025 · Filed Nov 5, 2025
FMR LLC reported a 8.30% stake in Cartesian Therapeutics, Inc., 2,155,783 shares, as a passive investor on Sep 30, 2025. Filed Nov 5, 2025 (Schedule 13G/A).
- Stake
- 8.30%
- Shares
- 2,155,783
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| FMR LLC | 8.30% | 2,155,783 |
| Abigail P. Johnson | 8.30% | 2,155,783 |
Source
Related
- Cartesian Therapeutics, Inc.
- FMR LLC
- Cartesian Therapeutics, Inc. shareholders
- Schedule 13G/A · FMR LLC · May 6, 2026
- Schedule 13G/A · FMR LLC · Feb 5, 2026
- Schedule 13G/A · FMR LLC · Feb 12, 2025
- Schedule 13G · Barclays PLC · Aug 13, 2026
- Schedule 13G/A · JPMorgan Chase & Co · Jul 22, 2026
- Form 4 · Hoge Elizabeth · Apr 6, 2026
- Form 4 · Kalayoglu Murat · Apr 6, 2026
- Schedule 13G · Squarepoint Ops LLC · Mar 13, 2026